Suven Life Sciences Ltd.
SUVEN Share PricePharmaceuticals & Drugs
₹171.6
-1.5 (-0.8%)
As on December 4, 2025
Exchange Scrips: BSE530239NSESUVENISININE495B01038
Market Cap ₹ 3,883 Cr
P/E Ratio -23.28
Dividend Yield N/A
Performance
Market performance
Open172.45
High172.93
Volumes1,81,947
Prev171.6
Low166.98
As on2025-12-04
Historical performance
1 Year High299.99
3 Year High299.99
5 Year High299.99
1 Year Low102.5
3 Year Low45
5 Year Low45
Fundamentals
Company Valuation
Market Cap (₹Cr)
3,883
Face Value (₹)
1
P/E Ratio
-23.28
Dividend Yield
N/A
Investment Returns
1 Year
27.8%
3 Years
171.3%
5 Years
239.3%
10 Years
-28.7%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 172.48 | Bearish |
| 10-DMA | 172.79 | Bearish |
| 20-DMA | 178.08 | Bearish |
| 50-DMA | 192.54 | Bearish |
| 100-DMA | 220 | Bearish |
| 200-DMA | 195.01 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 6 | 6 | 6 | 6 | 6 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 6 | 6 | 6 | 6 | 6 |
| Public Investors | 64915 | 66153 | 64597 | 63531 | 63969 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of -23.28.
- 3Y Stock Price CAGR of the stock is 38.6.
- The stock has a beta of 0.9.
- In the last financial year, the company had an EBITDA of ₹-1548 Million.
- The company generated revenue of ₹67 Million in the previous financial year.
Suven Life Sciences Ltd.
171.6-1.5 (-0.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1282032.1
No. of Shares: 7471 (Approx)
Performance:28.2%
P/L: ₹282032.1
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
